| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-16 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.35 | 1e-16 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.3 | 1e-11 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-10 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-07 |